000 01103 a2200289 4500
005 20250516021336.0
264 0 _c20110601
008 201106s 0 0 eng d
022 _a1879-0372
024 7 _a10.1016/j.coi.2010.12.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTurtle, Cameron J
245 0 0 _aGenetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy.
_h[electronic resource]
260 _bCurrent opinion in immunology
_cApr 2011
300 _a299-305 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aCD8-Positive T-Lymphocytes
_xcytology
650 0 4 _aCell Differentiation
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aNeoplasms
_ximmunology
700 1 _aRiddell, Stanley R
773 0 _tCurrent opinion in immunology
_gvol. 23
_gno. 2
_gp. 299-305
856 4 0 _uhttps://doi.org/10.1016/j.coi.2010.12.012
_zAvailable from publisher's website
999 _c20520443
_d20520443